Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Dorothy Brooks

Acoramidis Slowed the Decline in Daily Function for Amyloid Heart Disease Patients, a New Trial Analysis Finds

Inside the 30-Month Health Status Numbers

A new analysis of a completed phase 3 trial reports that patients with a frequently missed form of heart disease held onto more of their daily function over two and a half years when treated with an oral drug, though their function still declined.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.